Surface Logix Raises Series D

Surface Logix Inc., a Brighton, Mass.-based developer of drug optimization programs, has raised $19.9 million in Series D funding, according to a regulatory filing. Return backers include Venrock Associates, Arch Venture Partners, Unilever Ventures, HBM BioVentures and CW Ventures. It has now raised around $75 million in total VC funding since its 2000 inception. www.surfacelogix.com